Two-Year Medical Device Reporting Window Retained In New FDA Final MDR Guidance

The US agency has clarified its current thinking on Medical Device Reporting in a new final guidance that allows manufacturers to continue using a so-called “two-year rule” that lets them stop sending MDRs to the agency after 24 months. Overall, the guidance is a roadmap for how firms should structure MDR programs.

US FDA has clarified its current thinking on Medical Device Reporting in a new final guidance that allows manufacturers to continue using a so-called “two-year rule” that lets them stop sending MDRs to the agency if there are no additional product problems after 24 months.

Overall, the guidance released on Nov. 8 is a roadmap for how firms should structure MDR programs to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America